What if you'd held BCTX?
A $1,000 investment in BriaCell Therapeutics Corp. (BCTX) at the month-end close of 2012-03 would be worth $2.53 at the close of 2026-08 — -99.7% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $5,473.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2012
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2012 | $1,000 | — |
| 2013 | $400 | -60.0% |
| 2014 | $860 | +114.9% |
| 2015 | $1,105 | +28.6% |
| 2016 | $921 | -16.7% |
| 2017 | $614 | -33.3% |
| 2018 | $307 | -50.0% |
| 2019 | $184 | -40.0% |
| 2020 | $85.35 | -53.7% |
| 2021 | $169 | +98.6% |
| 2022 | $89.44 | -47.2% |
| 2023 | $120 | +33.9% |
| 2024 | $11.46 | -90.4% |
| 2025 | $14.55 | +27.0% |
| 2026 | $8.10 | -44.3% |
Best and worst month-end to buy
The best single month-end close to have bought BCTX was 2026-06 ($3.24): $1,000 then is $1,222 today. The worst was 2012-03 ($1,564): $1,000 then is $2.53.
FAQ
What would $1,000 in BCTX be worth today?
A $1,000 investment in BriaCell Therapeutics Corp. (BCTX) at the start of 2012 would be worth about $2.53 today, a total return of -99.7%. Dividends are reinvested in these figures.
What were the best and worst years for BCTX?
BriaCell Therapeutics Corp. (BCTX)'s strongest calendar year since 2012 was 2014, a +114.9% return — $1,000 held through that year became about $2,149 by year-end. Its weakest year was 2024, at -90.4%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in BCTX have grown?
Investing $100 at the end of every month since 2012-03 would have grown to about $2,002 on $17,400 invested.
Did BCTX beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $5,473. BCTX trailed the S&P 500 by +100.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
BriaCell Therapeutics Corp. (BCTX) historical total-return data from 2012-03 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.